ROTATION MEDICAL TENDON STAPLES (8) (broad indication)-Intended for fixation of prosthetic materi...
FDA Device Recall #Z-3096-2024 — Class II — August 12, 2024
Recall Summary
| Recall Number | Z-3096-2024 |
| Classification | Class II — Moderate risk |
| Date Initiated | August 12, 2024 |
| Status | Ongoing |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Smith & Nephew Inc. |
| Location | Andover, MA |
| Product Type | Devices |
| Quantity | US: 6305 units; OUS : 160 units |
Product Description
ROTATION MEDICAL TENDON STAPLES (8) (broad indication)-Intended for fixation of prosthetic material to soft tissues. Product Number: 2504-1
Reason for Recall
Product packaging process may result in an improper or incomplete seal of the outer foil pouch surrounding the inner Tyvek pouch, compromising product sterility
Distribution Pattern
Worldwide distribution - US Nationwide and the countries of Australia, Belgium, Canada, Chile, China, France, Germany, Great Britain, Greece, Hong Kong, India, Italy, Japan, Lithuania, Malaysia, Malta, New Zealand, Poland, Portugal, Puerto Rico, Romania, Singapore, Slovenia, South Africa, Spain, Switzerland, United Arab Emirates/Dubai (UAE).
Lot / Code Information
UDI-DI: 00854501006067 Batch Number 51180055 51180056 51180057 51180058 51180059 51180060 51180061 51180062 51180063 51180064 51180065 51184280 51184281 51184282 51184283 51184284 51184285 51184286 51184287 51184288 51184289 51184290 51185286 51185287 51185288 51185289 Batch Number 51185290 51185291 51185292 51185293 51185294 51185295 51185296 51189247 51189249 51189250 51189251 51189252 51189254 51189255 51189256 51189257 51189258 51189259 51193811 51193816 51193818 51193820
Other Recalls from Smith & Nephew Inc.
| Recall # | Classification | Product | Date |
|---|---|---|---|
| Z-0581-2025 | Class II | BIORAPTOR Suture Anchors. Tendon/ligament, non-... | Oct 29, 2024 |
| Z-3097-2024 | Class II | ROTATION MEDICAL TENDON STAPLES (8) (narrow in... | Aug 12, 2024 |
| Z-1162-2014 | Class II | Smith & Nephew RENASYS-AB Abdominal Dressing K... | Jan 9, 2014 |
| Z-1157-2014 | Class II | Smith & Nephew RENASYS Soft Port REF: 6680079... | Jan 9, 2014 |
| Z-1158-2014 | Class II | Smith & Nephew RENASYS-F Foam Dressing Kit wit... | Jan 9, 2014 |
Frequently Asked Questions
Sterility recalls for medical devices vary in severity. If you have already had a procedure using a potentially non-sterile device, contact your healthcare provider immediately — you may need monitoring for signs of infection. Symptoms to watch for include fever, redness or swelling at the surgical site, unusual pain, or discharge. For devices that have not yet been used, they should be quarantined and returned to the manufacturer per the recall notice. Non-sterile implants can cause serious infections; early detection and treatment are critical.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.